Literature DB >> 20087293

Therapeutic use of growth factors in the musculoskeletal system in sports-related injuries.

N Bachl1, W Derman, L Engebretsen, G Goldspink, M Kinzlbauer, H Tschan, P Volpi, D Venter, B Wessner.   

Abstract

Growth factors (GFs) act as signalling agents for cells and become a more and more popular mean to influence the human body and its tissues. This review gives an overview of the current possibilities to use such agents in the field of sports related injuries and thus providing the athlete with a whole new potential to minimize recovery time. GFs and its application have been studied intensively for a long time starting with animal studies. For some of this GFs this research has been brought onto the next level to clinical phase trials. Agents such as insulin like growth factor 1 (IGF-1), mechano growth factor (MGF), basic fibroblast growth factor (B-FGF), platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor b (TGF-b), bone morphogenetic protein (BMP) and leukemia inhibitory factor (LIF) are being discussed in this review. These GFs not only have the potential to be used to cure injuries but also are being in the centre of interest for doping abusers and are a powerful yet not fully understood technique to gain performance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20087293

Source DB:  PubMed          Journal:  J Sports Med Phys Fitness        ISSN: 0022-4707            Impact factor:   1.637


  9 in total

1.  Does single intramuscular application of autologous conditioned plasma influence systemic circulating growth factors?

Authors:  Gert Schippinger; Florian Fankhauser; Karl Oettl; Stefan Spirk; Peter Hofmann
Journal:  J Sports Sci Med       Date:  2012-09-01       Impact factor: 2.988

Review 2.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Growth Factor Roles in Soft Tissue Physiology and Pathophysiology.

Authors:  Jennifer H Roberts; Jaroslava Halper
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?

Authors:  Barbara Zabłocka; Paul H Goldspink; Geoffrey Goldspink; Dariusz C Górecki
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-01       Impact factor: 5.555

5.  Impaired musculoskeletal response to age and exercise in PPARβ(-/-) diabetic mice.

Authors:  He Fu; Beatrice Desvergne; Serge Ferrari; Nicolas Bonnet
Journal:  Endocrinology       Date:  2014-10-03       Impact factor: 4.736

6.  Growth factor levels in leukocyte-poor platelet-rich plasma and correlations with donor age, gender, and platelets in the Japanese population.

Authors:  Yu Taniguchi; Tomokazu Yoshioka; Hisashi Sugaya; Masahiko Gosho; Katsuya Aoto; Akihiro Kanamori; Masashi Yamazaki
Journal:  J Exp Orthop       Date:  2019-02-02

Review 7.  Feasibility of Growth Factor Agent Therapy in Repairing Motor Injury.

Authors:  Qiaoyin Tan; Jiayu Li; Yuwen Liu; Xiaojuan Zhu; Weide Shao
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

8.  Adenoviral Delivery of the VEGF and BMP-6 Genes to Rat Mesenchymal Stem Cells Potentiates Osteogenesis.

Authors:  Jesse Seamon; Xiuli Wang; Fuai Cui; Tom Keller; Abhijit S Dighe; Gary Balian; Quanjun Cui
Journal:  Bone Marrow Res       Date:  2013-02-26

9.  A combined cell and growth factor delivery for the repair of a critical size tibia defect using biodegradable hydrogel implants.

Authors:  Talia Cohen; Olga Kossover; Eli Peled; Tova Bick; Lena Hasanov; Tan Tuan Chun; Simon Cool; Dina Lewinson; Dror Seliktar
Journal:  J Tissue Eng Regen Med       Date:  2022-02-04       Impact factor: 4.323

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.